If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

While the exact cause of asthma is unknown, certain genetic factors can increase the risk of developing the disease.

Although cost-related asthma treatment nonadherence has declined in the US, nearly 1 in 6 patients are still nonadherent due to cost concerns.

Asthma is a chronic lung condition characterised by recurrent attacks of breathlessness, often accompanied by wheezing. Asthma is due to inflammation in the air passages of the lungs, causing ...

"Because asthma is a highly variable disease with ... Dr. Celedón mentioned that there is a better treatment for the T2-high disease because research has progressed quickly with this variant.

Arterial-Blood Studies during Treatment of Severe Refractory Bronchial Asthma in Case 2 on May 17, after Theophylline and Epinephrine (1), at 8:00 A.M., when the Asthma Was Refractory to ...

A doctor can diagnose your condition and recommend treatment based on your symptoms. If you’ve already been diagnosed with asthma, continue getting regular checkups from your doctor. This allows ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...

Impacting millions of children in the U.S. alone, asthma can be particularly problematic to diagnose with specificity — ...

A simple, noninvasive nasal swab identified a predominance of T2-low asthma subtypes in racial and ethnic minority pediatric ...